株式会社リボルナバイオサイエンス
Japan
unknown
unknown
Stage
About
株式会社リボルナバイオサイエンス develops small-molecule therapeutics that directly target RNA using a proprietary screening platform (RNA Insight and RNA Domino), focusing initially on rare genetic and neurological diseases and pursuing partnerships with major pharma as well as internal pipeline development.
Explore 株式会社リボルナバイオサイエンス's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.